COMPANY PROFILE

LaserGen

Explore full profile

A biotechnology company focused on commercializing novel technologies for DNA sequencing

Houston, United StatesFounded 2002Biotech & Life Sciences

Valuation $100–250M Last recorded · 2018

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About LaserGen

Lasergen, now part of Agilent, specializes in developing and building innovative life science instrumentation. The company serves clinical diagnostics labs and life science research facilities, offering a range of products including the K6460 LC MS system, which is a fully validated and easily implemented solution for clinical diagnostics. Lasergen operates in the life sciences market, focusing on enhancing lab productivity and providing comprehensive solutions for glycan analysis and cell analysis platforms. The business model revolves around selling advanced scientific instruments and providing technical expertise through webinars and other educational resources. Revenue is generated through the sale of these high-performance instruments and related services.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2002
Headquarters: Houston, United States
Employees: 1
Open positions: None listed
Dealroom signal: 28.0/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Chemistry, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Apr 2018	$105M	$105M	Agilent	—
SERIES BOther financing	Mar 2016	$80M	$320M	Agilent	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

LaserGen website traffic

Latest recorded traffic for LaserGen is 0 monthly website visits. LaserGen's team declined 50% over the past year.

Latest monthly visits0 1-year team growth-50%

Monthly website visitsApr 2016–May 2020

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
RBReactive Biosciences (Formerly Boragen)Refining the unique characteristics of boron to deliver solutions that make a difference	United States	Operational	2	$36M	$94M
STSeekyo TherapeuticsA privately-owned biotech company developing a Smart Chemotherapy, selective to tumours, safe for patients	Saint-Maur-des-Fossés, France	Operational
GOGoodGutFocused on researching and developing analysis systems and therapeutic products to improve the diagnosis and treatment of digestive diseases based on intestinal microbiota	Girona, Spain	Operational
BIBiotrendBiotrend: bioprocess development in Industrial Biotechnology. Biotechnology	Cantanhede, Portugal	Operational
IPIproteosBiotechnology company determined to improve human health by creating therapeutics for unmet medical needs in the central nervous system space	Barcelona, Spain	Acquired
TUTubulisGenerates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology	Planegg, Germany	Acquired
ONOncoinventDevelops new radiopharmaceutical products for better treatment options for cancer patients	Oslo, Norway	Operational
PRPrecirixCamelid-derived radiopharmaceuticals for targeted cancer therapy	Jette, Belgium	Operational